期刊论文详细信息
FEBS Letters
Different epitopes are required for gp130 activation by interleukin‐6, oncostatin M and leukemia inhibitory factor
Pflanz, Stefan1  Grötzinger, Joachim1  Müller-Newen, Gerhard1  Timmermann, Andreas1  Kurth, Ingo1  Küster, Andrea1  Heinrich, Peter C.1  Pitard, Vincent2 
[1] Institut für Biochemie, Rheinisch-Westfälische Technische Hochschule Aachen, Pauwelsstraße 30, D-52057 Aachen, Germany;CNRS-UMR 5540, Fédération de Recherche No. 60, Université de Bordeaux 2, 146 rue Léo-Saignat, 33076 Bordeaux Cedex, France
关键词: gp130;    Cytokine;    Receptor;    Signal transduction;    Ba/F3 cell;    CBM;    cytokine binding module;    D;    domain;    LIF;    leukemia inhibitory factor;    OSM;    oncostatin M;    s;    soluble;    STAT;    signal transducer and activator of transcription;   
DOI  :  10.1016/S0014-5793(00)01205-9
学科分类:生物化学/生物物理
来源: John Wiley & Sons Ltd.
PDF
【 摘 要 】

Gp130 is the common signal transducing receptor subunit of interleukin (IL)-6, IL-11, leukemia inhibitory factor (LIF), oncostatin M (OSM), ciliary neurotrophic factor and cardiotrophin-1. IL-6 and IL-11 induce gp130 homodimerization whereas the others lead to the formation of heterodimers with LIFR or OSMR. Binding epitopes for IL-6 and IL-11 are located in the immunoglobulin-like domain and the cytokine binding module (CBM). Here we show that a gp130 mutant lacking domain 1, although unresponsive to IL-6 and IL-11, can still activate signal transducer and activator of transcription (STAT) transcription factors in response to LIF or OSM. Moreover, point mutations in the CBM of gp130 (F191E and V252D) that severely impair signal transduction in response to IL-6 and IL-11 differentially interfere with gp130 activation in response to LIF and OSM. Thus, epitopes involved in gp130 homodimerization are distinct from those leading to the formation of gp130/LIFR or gp130/OSMR heterodimers. These findings may serve as the base for rational design of gp130 antagonists that specifically interfere with bioactivity of distinct IL-6-type cytokines.

【 授权许可】

Unknown   

【 预 览 】
附件列表
Files Size Format View
RO201912020309044ZK.pdf 394KB PDF download
  文献评价指标  
  下载次数:36次 浏览次数:28次